{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:56:28Z","timestamp":1760853388172,"version":"3.44.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.amjmed.2008.04.015","type":"journal-article","created":{"date-parts":[[2008,9,26]],"date-time":"2008-09-26T04:09:44Z","timestamp":1222402184000},"page":"835-844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Extensively Drug-resistant Tuberculosis"],"prefix":"10.1016","volume":"121","author":[{"given":"Miguel G.","family":"Madariaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umesh G.","family":"Lalloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Swindells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2008.04.015_bib1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2008.04.015_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3201\/eid1303.061400","article-title":"Worldwide emergence of extensively drug-resistant tuberculosis","volume":"13","author":"Shah","year":"2007","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib3","first-page":"301","article-title":"Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs\u2014worldwide, 2000-2004","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.amjmed.2008.04.015_bib4","first-page":"1576","article-title":"Notice to readers: revised definition of extensively drug-resistant tuberculosis","volume":"55","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.amjmed.2008.04.015_bib5","unstructured":"Friedland G. Confronting the catastrophe of M\/XDR TB. Presented at: 15th Conference on Retroviruses and Opportunistic Infections, February 3-6, 2008; Boston, Massachusetts."},{"key":"10.1016\/j.amjmed.2008.04.015_bib6","first-page":"318","article-title":"XDR-TB or not XDR-TB?","volume":"97","author":"Bateman","year":"2007","journal-title":"S Afr Med J."},{"key":"10.1016\/j.amjmed.2008.04.015_bib7","first-page":"760","article-title":"Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus","volume":"8","author":"Kam","year":"2004","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1183\/09031936.00037207","article-title":"A 10-year prospective surveillance of Mycobacterium tuberculosis drug resistance in France 1995-2004","volume":"30","author":"Khu\u00ea","year":"2007","journal-title":"Eur Respir J."},{"key":"10.1016\/j.amjmed.2008.04.015_bib9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s10096-005-1284-z","article-title":"Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs","volume":"24","author":"Toungoussova","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib10","first-page":"216","article-title":"Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates","volume":"9","author":"Prammananan","year":"2005","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib11","first-page":"882","article-title":"Notification of patients with tuberculosis detected in the private sector, Tehran, Iran","volume":"11","author":"Masjedi","year":"2007","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib14","first-page":"355","article-title":"Tuberculosis bacteriology\u2014priorities and indications in high prevalence countries: position of the technical staff of the Tuberculosis Division of the International Union Against Tuberculosis and Lung Disease","volume":"9","year":"2005","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib16","first-page":"250","article-title":"Extensively drug-resistant tuberculosis\u2014United States, 1993-2006","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.amjmed.2008.04.015_bib17","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1086\/522988","article-title":"Extensively drug-resistant Mycobacterium tuberculosis: Charles Darwin would understand","volume":"45","author":"Iseman","year":"2007","journal-title":"Clin Infect Dis."},{"issue":"Suppl 3","key":"10.1016\/j.amjmed.2008.04.015_bib18","doi-asserted-by":"crossref","first-page":"S482","DOI":"10.1086\/521121","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa","volume":"196","author":"Andrews","year":"2007","journal-title":"J Infect Dis."},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2008.04.015_bib19","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1086\/518665","article-title":"HIV infection and multidrug-resistant tuberculosis: the perfect storm","volume":"196","author":"Wells","year":"2007","journal-title":"J Infect Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJM199902043400507","article-title":"Tuberculosis in patients with human immunodeficiency virus infection","volume":"340","author":"Havlir","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjmed.2008.04.015_bib21","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199304223281601","article-title":"Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection","volume":"328","author":"Small","year":"1993","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjmed.2008.04.015_bib22","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1086\/378676","article-title":"Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease","volume":"188","author":"Toossi","year":"2003","journal-title":"J Infect Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/ajrccm.151.1.7812542","article-title":"Accelerated course of human immunodeficiency virus infection after tuberculosis","volume":"151","author":"Whalen","year":"1995","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.amjmed.2008.04.015_bib24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMp068273","article-title":"XDR tuberculosis\u2014implications for global public health","volume":"356","author":"Raviglione","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjmed.2008.04.015_bib25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(07)60341-9","article-title":"XDR tuberculosis spreads across South Africa","volume":"369","author":"Kapp","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2008.04.015_bib26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3122\/jabfm.2007.06.070109","article-title":"Clinical utility of interferon gamma assay in the diagnosis of tuberculosis","volume":"20","author":"Madariaga","year":"2007","journal-title":"J Am Board Fam Med."},{"key":"10.1016\/j.amjmed.2008.04.015_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","article-title":"Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review","volume":"4","author":"Pai","year":"2004","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1164\/rccm.200608-1088OC","article-title":"Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals","volume":"175","author":"Luetkemeyer","year":"2007","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.amjmed.2008.04.015_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3346\/jkms.2007.22.1.26","article-title":"The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results","volume":"22","author":"Joh","year":"2007","journal-title":"J Korean Med Sci."},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2008.04.015_bib30","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1086\/518656","article-title":"Facing the crisis: improving the diagnosis of tuberculosis in the HIV era","volume":"196","author":"Perkins","year":"2007","journal-title":"J Infect Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib31","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/JCM.38.3.1203-1208.2000","article-title":"Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures","volume":"38","author":"Caviedes","year":"2000","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.amjmed.2008.04.015_bib32","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa055524","article-title":"Microscopic-observation drug-susceptibility assay for the diagnosis of TB","volume":"355","author":"Moore","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjmed.2008.04.015_bib33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/511639","article-title":"Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis","volume":"44","author":"Arias","year":"2007","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib34","first-page":"468","article-title":"Drug susceptibility of Mycobacterium tuberculosis to primary antitubercular drugs by nitrate reductase assay","volume":"120","author":"Sethi","year":"2004","journal-title":"Indian J Med Res."},{"key":"10.1016\/j.amjmed.2008.04.015_bib35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/jac\/dki023","article-title":"Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis","volume":"55","author":"Montoro","year":"2005","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.amjmed.2008.04.015_bib36","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1128\/JCM.43.4.1612-1616.2005","article-title":"Rapid detection of ofloxacin resistance in Mycobacterium tuberculosis by two low-cost colorimetric methods: resazurin and nitrate reductase assays","volume":"43","author":"Martin","year":"2005","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.amjmed.2008.04.015_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/PL00011234","article-title":"Comparison of two rapid colorimetric methods for determining resistance of Mycobacterium tuberculosis to rifampin, isoniazid, and streptomycin in liquid medium","volume":"20","author":"De Logu","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib38","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1128\/jcm.33.9.2324-2327.1995","article-title":"Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis","volume":"33","author":"Yajko","year":"1995","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.amjmed.2008.04.015_bib39","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","article-title":"Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis","volume":"46","author":"Palomino","year":"2002","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.amjmed.2008.04.015_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/dkl477","article-title":"Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis","volume":"59","author":"Martin","year":"2007","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.amjmed.2008.04.015_bib41","first-page":"253","article-title":"A microplate indicator-based method for determining the susceptibility of multidrug-resistant Mycobacterium tuberculosis to antimicrobial agents","volume":"8","author":"Morcillo","year":"2004","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib42","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1128\/AAC.47.11.3616-3619.2003","article-title":"Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method","volume":"47","author":"Martin","year":"2003","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.amjmed.2008.04.015_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jinf.2005.05.017","article-title":"Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis","volume":"51","author":"Pai","year":"2005","journal-title":"J Infect."},{"key":"10.1016\/j.amjmed.2008.04.015_bib44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1099\/jmm.0.05149-0","article-title":"Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages","volume":"52","author":"Banaiee","year":"2003","journal-title":"J Med Microbiol."},{"key":"10.1016\/j.amjmed.2008.04.015_bib45","first-page":"858","article-title":"Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape","volume":"97","author":"Albert","year":"2007","journal-title":"S Afr Med J."},{"key":"10.1016\/j.amjmed.2008.04.015_bib46","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/jcm.35.3.719-723.1997","article-title":"Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level","volume":"35","author":"Telenti","year":"1997","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.amjmed.2008.04.015_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/AAC.44.1.103-110.2000","article-title":"Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing","volume":"44","author":"Piatek","year":"2000","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.amjmed.2008.04.015_bib48","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1128\/JCM.40.7.2509-2512.2002","article-title":"Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-specific PCR assay targeting katG codon 315 variation","volume":"40","author":"Mokrousov","year":"2002","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.amjmed.2008.04.015_bib49","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/JCM.00521-07","article-title":"Evaluation of the GenoType MTBDR plus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens","volume":"45","author":"Hillemann","year":"2007","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.amjmed.2008.04.015_bib50","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1128\/JCM.01332-06","article-title":"Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay","volume":"44","author":"Traore","year":"2006","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.amjmed.2008.04.015_bib51","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/JCM.02343-07","article-title":"Fluorometric assay for testing rifampin susceptibility of Mycobacterium tuberculosis complex","volume":"46","author":"Hoek","year":"2008","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.amjmed.2008.04.015_bib52","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1473-3099(06)70549-7","article-title":"Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis\/HIV collaboration","volume":"6","author":"Reid","year":"2006","journal-title":"Lancet Infect Dis."},{"year":"2006","series-title":"Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis","key":"10.1016\/j.amjmed.2008.04.015_bib54"},{"year":"2008","series-title":"Drug-resistant tuberculosis: a survival guide for clinicians","author":"Francis","key":"10.1016\/j.amjmed.2008.04.015_bib55"},{"key":"10.1016\/j.amjmed.2008.04.015_bib56","first-page":"367","article-title":"Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis","volume":"123","author":"Dickinson","year":"1981","journal-title":"Am Rev Respir Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib57","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3201\/eid1209.051618","article-title":"Multidrug-resistant tuberculosis management in resource-limited settings","volume":"12","author":"Nathanson","year":"2006","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib58","first-page":"189","article-title":"Drug-resistance test for kanamycin and cross resistance problem in Mycobacterium tuberculosis with special reference to kanamycin, streptomycin, and viomycin","volume":"12","author":"Tsukamura","year":"1959","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.amjmed.2008.04.015_bib59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0041-3879(77)80007-X","article-title":"Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin","volume":"58","author":"McClatchy","year":"1977","journal-title":"Tubercle"},{"key":"10.1016\/j.amjmed.2008.04.015_bib60","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1164\/rccm.200407-885OC","article-title":"Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis","volume":"170","author":"Nuermberger","year":"2004","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.amjmed.2008.04.015_bib61","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/rccm.200603-360OC","article-title":"Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis","volume":"174","author":"Burman","year":"2006","journal-title":"Am J Respir Crit Care Med."},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2008.04.015_bib62","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/518663","article-title":"New tuberculosis therapeutics: a growing pipeline","volume":"196","author":"Spigelman","year":"2007","journal-title":"J Infect Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib63","first-page":"441","article-title":"Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults","volume":"1","author":"Okwera","year":"1997","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib64","unstructured":"Daley CL. Treatment and clinical outcome of patients infected with an MDR\/XDR strain. Presented at: 38th Union World Conference on Lung Health, November 8-12, 2007, Cape Town, South Africa."},{"key":"10.1016\/j.amjmed.2008.04.015_bib65","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1086\/430066","article-title":"Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents","volume":"40","author":"Drobac","year":"2005","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.amjmed.2008.04.015_bib66","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1542\/peds.2005-2235","article-title":"Community-based therapy for children with multidrug-resistant tuberculosis","volume":"117","author":"Drobac","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.amjmed.2008.04.015_bib67","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1128\/AAC.00766-06","article-title":"Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration","volume":"50","author":"Lounis","year":"2006","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.amjmed.2008.04.015_bib68","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1128\/AAC.49.6.2294-2301.2005","article-title":"Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models","volume":"49","author":"Lenaerts","year":"2005","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.amjmed.2008.04.015_bib69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.mcp.0000219266.27439.52","article-title":"Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis","volume":"12","author":"Lalloo","year":"2006","journal-title":"Curr Opin Pulm Med."},{"year":"2008","series-title":"Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents","key":"10.1016\/j.amjmed.2008.04.015_bib70"},{"year":"2006","series-title":"Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach","key":"10.1016\/j.amjmed.2008.04.015_bib71"},{"year":"2004","series-title":"Tuberculosis TB\/HIV: A Clinical Manual","key":"10.1016\/j.amjmed.2008.04.015_bib72"},{"key":"10.1016\/j.amjmed.2008.04.015_bib73","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0b013e328011efac","article-title":"Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa","volume":"21","author":"Lawn","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2008.04.015_bib74","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2165\/00003495-200666180-00003","article-title":"Tuberculosis and HIV co-infection: a practical therapeutic approach","volume":"66","author":"Breen","year":"2006","journal-title":"Drugs"},{"issue":"RR-11","key":"10.1016\/j.amjmed.2008.04.015_bib75","first-page":"61","article-title":"Management of persons exposed to multidrug-resistant tuberculosis","volume":"41","year":"1992","journal-title":"MMWR Recomm Rep."},{"key":"10.1016\/j.amjmed.2008.04.015_bib76","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Gu\u00e9rin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest."},{"key":"10.1016\/j.amjmed.2008.04.015_bib77","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med."},{"key":"10.1016\/j.amjmed.2008.04.015_bib78","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med."},{"key":"10.1016\/j.amjmed.2008.04.015_bib79","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ajim.4700270302","article-title":"Respiratory protection and the risk of Mycobacterium tuberculosis infection","volume":"27","author":"Nicas","year":"1995","journal-title":"Am J Ind Med."},{"year":"2006","series-title":"Tuberculosis and Air Travel: Guidelines for Prevention and Control","key":"10.1016\/j.amjmed.2008.04.015_bib80"},{"key":"10.1016\/j.amjmed.2008.04.015_bib81","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1371\/journal.pmed.0040050","article-title":"XDR-TB in South Africa: no time for denial or complacency","volume":"4","author":"Singh","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.amjmed.2008.04.015_bib82","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/bmj.39108.568368.DB","article-title":"Doctors disagree over detention of patients with extensively drug resistant tuberculosis","volume":"334","author":"Moszynski","year":"2007","journal-title":"BMJ"},{"year":"2008","series-title":"The global plan to stop TB","key":"10.1016\/j.amjmed.2008.04.015_bib83"},{"year":"2003","series-title":"The five elements of DOTS","key":"10.1016\/j.amjmed.2008.04.015_bib84"},{"key":"10.1016\/j.amjmed.2008.04.015_bib85","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa022928","article-title":"Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru","volume":"348","author":"Mitnick","year":"2003","journal-title":"N Engl J Med."},{"year":"2008","series-title":"Tuberculosis XDR-TB: the facts","key":"10.1016\/j.amjmed.2008.04.015_bib86"},{"key":"10.1016\/j.amjmed.2008.04.015_bib87","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nm0307-309","article-title":"Tuberculosis, a neglected opportunity?","volume":"13","author":"Harper","year":"2007","journal-title":"Nat Med."}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934308004348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934308004348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:49:14Z","timestamp":1757580554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934308004348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":83,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0002934308004348"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2008.04.015","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extensively Drug-resistant Tuberculosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2008.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}